Antiemetics

CBD Healthcare company Opticann launches ArthroCBD, a line of scientifically proven softgel capsules

Retrieved on: 
Wednesday, May 5, 2021
Herbalism, Medicinal plants, Cannabis smoking, Health sciences, Psychoactive drugs, Life sciences, Medicinal chemistry, Antiemetics, Medical cannabis, Bioavailability, OTC Markets Group, Drug

Much of the problem with other CBD products is the lack of effect due to poor absorption as only 8-10% of product is absorbed.

Key Points: 
  • Much of the problem with other CBD products is the lack of effect due to poor absorption as only 8-10% of product is absorbed.
  • Opticann\'s US products use VESIsorb, a proven technology that helps boost the performance of pharmaceutical and wellness products.
  • Opticann sells science-backed products made with the patented VESIsorb drug delivery system for optimized absorption and stability (bioavailability).
  • Opticann is owned by Heritage Cannabis Holdings Corp., a Toronto-based publicly traded corporation (CSE: CANN) (OTCQX: HERTF).

Delta 8 THC: Fresh Bros Explores the Reasons Why Delta 8 Products are Gaining in Popularity

Retrieved on: 
Monday, May 3, 2021
Drugs, Entheogens, Euphoriants, Appetite stimulants, Psychoactive drugs, Antiemetics, Cannabinoids, Branches of biology, Tetrahydrocannabinol, Hemp, Cannabis, Cannabidiol

Delta 8 is legal to buy online, so you can have complete peace of mind as long as you buy your products from a reputable supplier (after all, not all Delta 8 THC products are high quality!

Key Points: 
  • Delta 8 is legal to buy online, so you can have complete peace of mind as long as you buy your products from a reputable supplier (after all, not all Delta 8 THC products are high quality!
  • ).\nFresh Bros is a fully licensed and regulated CBD and hemp product manufacturer based in Las Vegas.
  • This is where Delta 8 truly shines, as these patients could take it to experience relief from pain and nausea without having to cope with any serious side effects.
  • In addition to providing relief from pain and nausea, Delta 8 offers some other great benefits to users, such as:\n'

Delta-8 Legal Map Released By Vapor Vanity

Retrieved on: 
Monday, May 3, 2021
Euphoriants, Cannabis, Psychoactive drugs, Appetite stimulants, Entheogens, Antiemetics, Drugs, Branches of biology, Tetrahydrocannabinol, Hemp, Medical cannabis, Legality of cannabis

[State-By-State] ', offers a clear picture of where you can legally purchase Delta-8 and where you can't.\nDelta-8 THC, also known as Delta-8 or D-8, is a relatively new cannabis compound that has seen a remarkable growth in the market.

Key Points: 
  • [State-By-State] ', offers a clear picture of where you can legally purchase Delta-8 and where you can't.\nDelta-8 THC, also known as Delta-8 or D-8, is a relatively new cannabis compound that has seen a remarkable growth in the market.
  • However, its sale, possession, and use aren't legal everywhere in the USA.\nSince the federal government legalized the production and sale of hemp-based products in 2014, the general public has taken to cannabinoids like honey.
  • But the buzz surrounding Delta-8 seems to have taken on a life of its own.
  • So, although D-8 is federally legal to produce, sell, and use, it's completely forbidden in these 11 states.\nThe reasons for that are as winding as they are complex.

CBD of Denver Provides Update on Swiss Pilot Program Permitting Temporary Production and Sale of Marijuana

Retrieved on: 
Monday, May 3, 2021
Herbalism, Medicinal plants, Health sciences, Antiemetics, Antioxidants, Medical cannabis, Cannabis, Branches of biology, Pharmaceutical sciences, Drug liberalization

Marijuana Business Daily reported that it could lead to the normalization of cannabis in Switzerland.

Key Points: 
  • Marijuana Business Daily reported that it could lead to the normalization of cannabis in Switzerland.
  • The pilot program is intended to provide scientific arguments for a national debate on the opportunity to legally regulate cannabis for adult consumers, according to an expert quoted in the Marijuana Business Daily article.
  • The upper house, the Conseil des Etats approved the bill in September.
  • We assume no obligation publicly about update or revise these forward-looking statements for any reason.\n'

Delta-8 THC Now Reported by LightLab 3 Cannabis Analyzer

Retrieved on: 
Thursday, April 29, 2021
Euphoriants, Psychoactive drugs, Entheogens, Medicinal plants, Drugs, Branches of biology, Antiemetics, Appetite stimulants, Tetrahydrocannabinol, Medical cannabis, Cannabis, Hemp

b'NEW LONDON, N.H., April 29, 2021 /PRNewswire/ -- Orange Photonics is pleased to announce that the LightLab 3 Cannabis Analyzer now reports Delta-8 THC (D8-THC), an increasingly popular cannabinoid found in hemp-derived cannabis products.

Key Points: 
  • b'NEW LONDON, N.H., April 29, 2021 /PRNewswire/ -- Orange Photonics is pleased to announce that the LightLab 3 Cannabis Analyzer now reports Delta-8 THC (D8-THC), an increasingly popular cannabinoid found in hemp-derived cannabis products.
  • Despite LightLab 3\'s significantly lower cost and simpler operation, we are pleased to be able to measure Delta-8 THC on the platform."
  • The Mobile Monitoring feature is available on every LightLab 3 Cannabis Analyzer.\nFounded in 2015, Orange Photonics is based in New Hampshire, USA.
  • LightLab Cannabis Analyzer, is a purpose-built, liquid chromatogram designed for non-technical users.

LB Pharmaceuticals To Participate in the B. Riley Securities’ Neuroscience Conference

Retrieved on: 
Monday, April 26, 2021
Research, Technology, Other Technology, Clinical trials, Biotechnology, General Health, Pharmaceutical, Health, Science, Other Science, Psychoactive drugs, Chemical compounds, Atypical antipsychotics, Receptor antagonists, Pyrrolidines, Amisulpride, Antidepressants, Antiemetics, Sulpiride, Placebo-controlled study

Following the presentation, Mr. Prensky will participate in a question-and-answer session.

Key Points: 
  • Following the presentation, Mr. Prensky will participate in a question-and-answer session.
  • Our approach is to create a research-focused organization dedicated to generating novel intellectual property around improved versions of these former best-selling drugs.
  • LB-102 has the potential to offer schizophrenia patients the benefits of amisulpride at a lower dose than amisulpride.
  • A first-in-human, double-blind placebo-controlled Phase 1 study designed to test the safety and pharmacokinetics of LB-102 was completed over the summer of 2020.

General Cannabis to Create Retail Footprint by Acquiring Trees Dispensaries

Retrieved on: 
Wednesday, April 21, 2021
Herbalism, Medicinal plants, Health sciences, Pharmaceutical sciences, Health care, Antiemetics, Antioxidants, Medical cannabis, Cannabis, Dispensary

Total revenue for General Cannabis nearly doubled in 2020 from 2019.\nTrees currently operates a dispensary in Denver, Colorado and two dispensaries in Portland, Oregon.

Key Points: 
  • Total revenue for General Cannabis nearly doubled in 2020 from 2019.\nTrees currently operates a dispensary in Denver, Colorado and two dispensaries in Portland, Oregon.
  • The addition of the Trees footprint will make General Cannabis vertically integrated in Colorado.\nCarl Williams, Chairman of the Board of General Cannabis, said, \xe2\x80\x9cThis is a transformational acquisition for us.
  • Equally important, we instantly develop a retail foundation and add personnel with deep retail experience.\xe2\x80\x9d\nWhen the transaction closes, the senior leadership of Trees will become an important part of the General Cannabis team.
  • In acquiring Trees, we are adding a retail platform that is successful today and will be the backbone of future growth.

Isracann Receives Foreign Owners License and Updates Israeli Cannabis Operations

Retrieved on: 
Wednesday, April 21, 2021
Health sciences, Antiemetics, Medical cannabis, Pharmaceuticals policy, Pharmacognosy, Leverage, Articles, Business

Today\xe2\x80\x99s announcement represents the removal of regulatory ownership barriers in order to fully execute the terms of the JV plan.\nThe highly sought-after foreign owners license significantly legitimizes the Company\xe2\x80\x99s presence in Israel.

Key Points: 
  • Today\xe2\x80\x99s announcement represents the removal of regulatory ownership barriers in order to fully execute the terms of the JV plan.\nThe highly sought-after foreign owners license significantly legitimizes the Company\xe2\x80\x99s presence in Israel.
  • There are only a small number of foreign owned sector participants who have obtained similar licencing, and Isracann is now favourably positioned to leverage certain advantages.
  • Largely due to COVID-19 related delays, Isracann has a final regulatory hurdle to conclude which appears to be moving closer to conclusion.
  • Based in Israel's agricultural sector, Isracann will leverage its development within the most experienced country in the world with respect to cannabis research.

Dama Financial, the Leading Provider of Access to Banking and Financial Solutions for Cannabis Businesses, Announces the Completion of $12.6 Million Growth Equity Raise

Retrieved on: 
Wednesday, April 21, 2021
Herbalism, Medicinal plants, Health sciences, Antiemetics, Antioxidants, Medical cannabis, Drugs in the United States, Pharmaceutical sciences, Decriminalization of non-medical cannabis in the United States

"We have spent four years building a platform to enable safe, compliant financial services for cannabis businesses and now is the time to take Dama to the next level.

Key Points: 
  • "We have spent four years building a platform to enable safe, compliant financial services for cannabis businesses and now is the time to take Dama to the next level.
  • "Dama continues to innovate solutions for the serious payments problems faced by the industry and we are excited to see that accelerate.
  • "\nSince November 2020, six new states have passed legalization measures for cannabis and a record-high percentage of Americans now support legalization.
  • The Company\'s expansive product set, including Premier Business Banking, Paytender and CashToTax, fueled 350% top line growth in 2020.\n'

Charlotte's Web Secures Health Canada Approval to Bring its Proprietary CBD Cultivars to Canada

Retrieved on: 
Tuesday, April 20, 2021
Euphoriants, Entheogens, Psychoactive drugs, Drugs, Medicinal plants, Cannabis, Herbs, Antiemetics, Hemp, Tetrahydrocannabinol, Medical cannabis, Effects of cannabis

The approved cultivars include the Company\'s original "CW1AS1" U.S. patented genetics, clearing the way for Charlotte\'s Web to cultivateits leading CBD wellness products in Canada in 2021.

Key Points: 
  • The approved cultivars include the Company\'s original "CW1AS1" U.S. patented genetics, clearing the way for Charlotte\'s Web to cultivateits leading CBD wellness products in Canada in 2021.
  • Most CBD products in Canada are produced from cannabis with THC levels well above 0.3% which have an intoxicating effect.
  • Charlotte\'s Web hemp cultivars are cultivated below 0.3% THC, resulting in full-spectrum extracts with wellness benefits, but without the intoxication from THC.\nCurrently, Health Canada treats hemp CBD under the same regulatory regime as cannabis THC.
  • Hemp CBD products could then be sold in all types of retailers across Canada, which would help meet demand for the product.